Annona haematantha
Annona haematantha · Accepted scientific name
Scientific literature: Very Sparse (0 studies) · ★☆☆☆☆
Annona haematantha is a botanical species that has garnered significant scientific interest due to its diverse therapeutic potential. Recent pharmacological investigations have focused on the plant's root, which serves as a rich source of bioactive compounds. Specifically, the hexanic extract of these roots has demonstrated notable biological activity in experimental models. Studies have identified the presence of Argentilactone within these extracts, contributing to their medicinal properties. This specific chemical profile suggests that the plant may hold promise in the treatment of conditions such as cutaneous Leishmaniasis.
- Synonyms
- Not available
- Common names
- Not available
- Family
- Annonaceae
- Distribution
- Asia-Temperate
- Plant Parts
- Root
Classification
Common Names
Annona haematantha is a distinctive botanical species recognized by many local communities by its common name, Karampai. This plant holds a significant place within its natural habitat, often serving as a vital component of the local ecosystem. Understanding its identity through such traditional naming conventions helps researchers connect scientific taxonomy with regional knowledge. By studying the Karampai, botanists can better appreciate the intricate relationships between specific flora and the environments they inhabit. Consequently, documenting these connections is essential for the ongoing preservation of diverse plant life.
Sources: Catalogue of Life (COL)
Taxonomy
Annona haematantha is a distinct biological entity belonging to the kingdom Plantae. Within this vast kingdom, the species is classified under the class Equisetopsida. It holds a specific place in the natural hierarchy as a member of the order Magnoliales. Furthermore, this plant is situated within the diverse family Annonaceae. Ultimately, its botanical identity is defined by its membership in the genus Annona.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Magnoliales |
| Family | Annonaceae |
| Genus | Annona |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Annona haematantha is a plant species primarily distributed throughout the diverse landscapes of Southern America. Its presence is notably widespread across Northern South America, including the territories of French Guiana, Guyana, and Suriname. In addition to these regions, the species can be found throughout various parts of Brazil. The plant also extends its reach into Western South America, specifically within the borders of Colombia. This broad geographical range highlights the adaptable nature of the species across the continent.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Morphology
Annona haematantha is a self-supporting tree that maintains a sturdy and independent growth form. This species typically reaches a maximum height of 10 meters as it matures in its natural habitat. Its structural characteristics make it a notable component of its local ecosystem.
Sources: Global Inventory of Floras and Traits (GIFT)
Biological Activities
Compounds
Annona haematantha serves as a significant botanical source for the isolation of argentilactone, an alpha,beta-unsaturated delta-lactone found within its root extracts. Scientific investigations have identified this specific compound for its potent biological properties against various strains of Leishmania ssp. In experimental models, argentilactone demonstrated remarkable efficacy in treating cutaneous leishmaniasis when administered to infected mice. The treatment proved capable of reducing parasite loads in lesions by 96%, matching the performance of standard reference drugs. Consequently, the relationship between this plant and its active constituent offers promising therapeutic potential for managing parasitic infections.
Conditions
Annona haematantha possesses medicinal properties capable of treating cutaneous leishmaniasis through its active compound, argentilactone. This specific alpha,beta-unsaturated delta-lactone was isolated from the hexanic extract of the plant's roots. In experimental studies, argentilactone demonstrated potent in vitro activity against various strains of Leishmania ssp. at a concentration of 10 micrograms/ml. When administered to infected mice, the compound proved to be as effective as the reference drug, N-methylglucamine antimonate. Specifically, the treatment successfully reduced parasite loads in lesions by 96% and decreased the parasite burden in the spleen by 50%.
Preparations
Annona haematantha is prepared as a hexanic extract derived from its roots. This specific extraction process was used to isolate an alpha,beta-unsaturated delta-lactone known as argentilactone. The resulting compound was subsequently tested for its efficacy against various strains of Leishmania ssp. In experimental settings, this hexanic extract derivative demonstrated significant potential in reducing parasite loads in both lesions and spleens. Consequently, the preparation of Annona haematantha through this method proved vital for identifying effective therapeutic agents.
Parts used
Annona haematantha contains specific chemical compounds that hold significant medicinal potential for treating parasitic infections. Researchers focused their investigation on the roots of this plant to isolate a unique alpha,beta-unsaturated delta-lactone known as argentilactone. This bioactive compound was extracted from the hexanic fraction of the root material and tested against various strains of Leishmania. In animal models, argentilactone demonstrated remarkable efficacy by significantly reducing parasite loads in both lesions and the spleen. These findings suggest that the root of Annona haematantha is a vital source of therapeutic agents for combating cutaneous leishmaniasis.